Influenza vaccine and risk of acute myocardial infarction in a population-based case–control study
- 13 October 2021
- Vol. 108 (13), 1039-1045
- https://doi.org/10.1136/heartjnl-2021-319754
Abstract
Objective To assess the relationship between influenza vaccination and risk of a first acute myocardial infarction (AMI) in the general population by different epidemic periods. Methods This is a population-based case–control study carried out in BIFAP (Base de datos para la investigación farmacoepidemiológica en atención primaria), over 2001–2015, in patients aged 40–99 years. Per each incident AMI case, five controls were randomly selected, individually matched for exact age, sex and index date (AMI diagnosis). A patient was considered vaccinated when he/she had a recorded influenza vaccination at least 14 days before the index date within the same season. The association between influenza vaccination and AMI risk was assessed through a conditional logistic regression, computing adjusted ORs (AOR) and their respective 95% CIs. The analysis was performed overall and by each of the three time epidemic periods per study year (pre-epidemic, epidemic and postepidemic). Results We identified 24 155 AMI cases and 120 775 matched controls. Of them, 31.4% and 31.2%, respectively, were vaccinated, yielding an AOR of 0.85 (95% CI 0.82 to 0.88). No effect modification by sex, age and background cardiovascular risk was observed. The reduced risk of AMI was observed shortly after vaccination and persisted over time. Similar results were obtained during the pre-epidemic (AOR=0.87; 95% CI 0.79 to 0.95), epidemic (AOR=0.89; 95% CI 0.82 to 0.96) and postepidemic (AOR=0.83; 95% CI 0.79 to 0.87) periods. No association was found with pneumococcal vaccine (AOR=1.10; 95% CI 1.06 to 1.15). Conclusions Results are compatible with a moderate protective effect of influenza vaccine on AMI in the general population, mostly in primary prevention, although bias due to unmeasured confounders may partly account for the results.Keywords
Funding Information
- Biomedical Research Foundation of the University Hospital Príncipe de Asturias
- Instituto de Salud Carlos III (# PI16/01353)
This publication has 33 references indexed in Scilit:
- Association Between Influenza Vaccination and Cardiovascular Outcomes in High-Risk PatientsJAMA, 2013
- Mycobacterium bovis BCG killed by extended freeze‐drying induces an immunoregulatory profile and protects against atherosclerosisJournal of Internal Medicine, 2013
- Influenza vaccination, pneumococcal vaccination and risk of acute myocardial infarction: matched case-control studyCMAJ : Canadian Medical Association Journal, 2010
- Influenza vaccination in secondary prevention from coronary ischaemic events in coronary artery disease: FLUCAD studyEuropean Heart Journal, 2008
- Functional status is a confounder of the association of influenza vaccine and risk of all cause mortality in seniorsInternational Journal of Epidemiology, 2005
- Evidence of bias in estimates of influenza vaccine effectiveness in seniorsInternational Journal of Epidemiology, 2005
- Annual Revaccination Against Influenza and Mortality Risk in Community-Dwelling Elderly PersonsJAMA, 2004
- Influenza Vaccination in Community-Dwelling ElderlyArchives of Internal Medicine, 2003
- Statistics Notes: Interaction revisited: the difference between two estimatesBMJ, 2003
- Excess Mortality from Causes Other than Influenza and Pneumonia during Influenza EpidemicsPublic Health Reports (1896-1970), 1932